Top Markets
#1 Verus Coin Verus Coin +19.70%
#2 Fake World Assets Fake World Assets +11.59%
#3 GoPlus Security GoPlus Security +4.67%
#4 Everything Everything +3.70%
#5 TronBank TronBank +3.67%
#6 TENDIES TENDIES +3.27%
#7 Tutorial Tutorial +3.00%
#8 Bedrock Bedrock +2.68%
#9 Humanity Humanity +2.36%
#10 Janction Janction +2.16%
Coin of the day
Verus Coin Verus Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Classifica tra le azioni #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Prezzo delle azioni
$0.617
Ultima sincronizzazione: 2024-10-14
Capitalizzazione di mercato
$6.13M
Variazione (1 giorno)
0.49%
Variazione (1 anno)
0.00%
Paese
US
Scambia Kineta, Inc. (KA)

Categoria

Healthcare
Rapporto P/B per Kineta, Inc. (KA)
Rapporto P/B al August 2026 TTM: -0.58
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Kineta, Inc., il rapporto P/B attuale (TTM) è -0.58. Alla fine del 2023, era pari a 13.88.
Storico del rapporto P/B per Kineta, Inc. da 2015 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) -0.58 -6.79%
2024 -0.62 -104.47%
2023 13.88 96.37%
2022 7.07 -463.47%
2021 -1.95 36.18%
2020 -1.43 -198.50%
2019 1.45 71.37%
2018 0.85 -49.33%
2017 1.67 -23.75%
2016 2.19 -92.84%
2015 30.60 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -1,197.40%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -1,180.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -698.93%
BE